The ongoing U.S. measles resurgence, driven by multiple active outbreaks primarily among unvaccinated populations, has produced 1,983 confirmed cases through May 28, 2026, according to CDC surveillance data—already approaching the full-year 2025 total of 2,288. Most cases are outbreak-associated and locally acquired, with 93% linked to sustained transmission in 30 jurisdictions, concentrated in children and adolescents. Weekly increments of 50–60 cases reflect continued community spread, though reporting lags and vaccination coverage gaps influence the pace. CDC updates, typically issued weekly, will provide the authoritative case counts through the June 30 resolution window, with any shifts in outbreak containment or new importations as key variables.
Resumen experimental generado por IA con datos de Polymarket. Esto no es asesoramiento de trading y no influye en cómo se resuelve este mercado. · ActualizadoMeasles cases in U.S. by June 30?
Measles cases in U.S. by June 30?
$19,285 Vol.
30 jun 2026
2150
30%
2200
9%
2300
7%
2400
3%
$19,285 Vol.
2150
$5,857 Vol.
30%
2200
$7,681 Vol.
9%
2300
$2,268 Vol.
7%
2400
$3,480 Vol.
3%
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by June 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.The ongoing U.S. measles resurgence, driven by multiple active outbreaks primarily among unvaccinated populations, has produced 1,983 confirmed cases through May 28, 2026, according to CDC surveillance data—already approaching the full-year 2025 total of 2,288. Most cases are outbreak-associated and locally acquired, with 93% linked to sustained transmission in 30 jurisdictions, concentrated in children and adolescents. Weekly increments of 50–60 cases reflect continued community spread, though reporting lags and vaccination coverage gaps influence the pace. CDC updates, typically issued weekly, will provide the authoritative case counts through the June 30 resolution window, with any shifts in outbreak containment or new importations as key variables.
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by June 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
Mercado abierto: May 28, 2026, 11:08 AM ET
Volumen
$19,285Fecha de finalización
30 jun 2026Mercado abierto
May 28, 2026, 11:08 AM ETResolver
0x65070BE91...This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by June 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.The ongoing U.S. measles resurgence, driven by multiple active outbreaks primarily among unvaccinated populations, has produced 1,983 confirmed cases through May 28, 2026, according to CDC surveillance data—already approaching the full-year 2025 total of 2,288. Most cases are outbreak-associated and locally acquired, with 93% linked to sustained transmission in 30 jurisdictions, concentrated in children and adolescents. Weekly increments of 50–60 cases reflect continued community spread, though reporting lags and vaccination coverage gaps influence the pace. CDC updates, typically issued weekly, will provide the authoritative case counts through the June 30 resolution window, with any shifts in outbreak containment or new importations as key variables.
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by June 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
Volumen
$19,285Fecha de finalización
30 jun 2026Mercado abierto
May 28, 2026, 11:08 AM ETResolver
0x65070BE91...The ongoing U.S. measles resurgence, driven by multiple active outbreaks primarily among unvaccinated populations, has produced 1,983 confirmed cases through May 28, 2026, according to CDC surveillance data—already approaching the full-year 2025 total of 2,288. Most cases are outbreak-associated and locally acquired, with 93% linked to sustained transmission in 30 jurisdictions, concentrated in children and adolescents. Weekly increments of 50–60 cases reflect continued community spread, though reporting lags and vaccination coverage gaps influence the pace. CDC updates, typically issued weekly, will provide the authoritative case counts through the June 30 resolution window, with any shifts in outbreak containment or new importations as key variables.
Resumen experimental generado por IA con datos de Polymarket. Esto no es asesoramiento de trading y no influye en cómo se resuelve este mercado. · Actualizado
Cuidado con los enlaces externos.
Cuidado con los enlaces externos.
Preguntas frecuentes